The Patent Finder

Terms ending in 2033

Millennium Pharmaceuticals, Inc.

Every in-force patent on Millennium Pharmaceuticals, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,663,525Pyrazolopyrimidinyl Inhibitors of Ubiquitin-Activating Enzyme
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 9,796,725Pyrazolopyrimidinyl Inhibitors of Ubiquitin-Activating Enzyme
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 10,202,389Pyrazolopyrimidinyl Inhibitors of Ubiquitin-Activating Enzyme
In force
 · Medium confidence
Takeda Pharmaceutical Company LimitedIn forceMedium confidence
US 10,213,436Methods of Treating Cancer Using Aurora Kinase Inhibitors
In force
 · High confidence
Millennium Pharmaceuticals, Inc.In forceHigh confidence
US 9,290,500Pyrazolopyrimidinyl Inhibitors of Ubiquitin-Activating Enzyme
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 9,000,129Anti-Gcc Antibody Molecules and Methods for Use of Same
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 9,273,146Anti-Gcc Antibody Molecules and Methods for Use of Same
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 9,593,121Indole-Substituted Pyrrolopyrimidinyl Inhibitors of UBA6
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 9,764,033Formulation for ANTI-ALPHA4BETA7 Antibody
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
US 12,286,479Treatment with ANTI-ALPHA4BETA7 Antibody
In force
 · High confidence
Takeda Pharmaceutical Company LimitedIn forceHigh confidence
1 more term end in 2033 · Pro
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11.
Upgrade to Pro
1 of these is in force and held by Millennium Pharmaceuticals, Inc..
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited